Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) hit a new 52-week high on Monday . The stock traded as high as $1.70 and last traded at $1.69, with a volume of 41219 shares traded. The stock had previously closed at $1.59.
BioRestorative Therapies Trading Up 6.0 %
The firm has a market capitalization of $2.76 billion, a P/E ratio of -1.49 and a beta of 102.36. The firm has a 50-day moving average of $1.70 and a two-hundred day moving average of $1.50.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- 3 Warren Buffett Stocks to Buy Now
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- Compound Interest and Why It Matters When Investing
- 2 Option Strategies to Maximize Profits in a Bear Market
- What Are Dividends? Buy the Best Dividend Stocks
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.